drugset / Trial / NCT00179998

Effectiveness of Pulmozyme in Infants With Cystic Fibrosis

NCT00179998 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a study to find out whether Pulmozyme is effective for clearing mucus from the airways of children with cystic fibrosis less than 3 ½ years of age.

Timeline

Start
2005-01
Primary completion
2008-10
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Recombinant Human DNase Unknown 2.5 mg Inhaled

Indications